Nadine Wong

Special to TheStreet.com

Nadine Wong
By This Author:
« Back
Page 1 of 4
Article

How to Evaluate Biotechs That Aren't Profitable Yet

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:50AM 01/24/02

Article

This Earnings Season Could Be a Good One for Biotechs

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:27AM 01/17/02

Article

Don't Write Off ImClone Just Yet

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

09:55AM 01/10/02

Article

ImClone's Potential Could Be Worth the Risk

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:03AM 01/03/02

Article

Biotech's Prognosis Improves at Year-End

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:58AM 12/27/01

Article

The Amgen-Immunex Deal Is the Right Prescription

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

09:25AM 12/20/01

Article

Protein Design Labs Is Still Worth Owning

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

10:54AM 12/13/01

Article

Who Wins, Who Loses in the MedImmune-Aviron Deal

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:10AM 12/06/01

Article

How to Play Stem-Cell Research Stocks

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

10:20AM 11/29/01

Article

Some Biotech Mutual Funds Worth Considering

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

07:31AM 11/21/01

« Back
Page 1 of 4
Dow Jones S&P 500 NASDAQ 10-Year Note
10,496.97 1,111.76 2,181.60 32.56
Oil *
79.89
UP
152.13
UP
16.13
UP
37.00
UP
0.55
10 Yr
3.26%
SPDR Gold
117.54
+1.47%
+1.47%
+1.73%
+1.72%
Data delayed 20 minutes

Brokerage Partners